Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2V617F Mice

被引:186
|
作者
Wang, Wei [1 ]
Liu, Wenli [1 ,3 ]
Fidler, Trevor [1 ]
Wang, Ying [1 ]
Tang, Yang [1 ]
Woods, Brittany [4 ,5 ]
Welch, Carrie [1 ]
Cai, Bishuang [1 ]
Silvestre-Roig, Carlos [6 ]
Ai, Ding [3 ]
Yang, Yong-Guang [2 ]
Hidalgo, Andres [6 ,7 ]
Soehnlein, Oliver [6 ,8 ,9 ]
Tabas, Ira [1 ]
Levine, Ross L. [4 ,5 ]
Tall, Alan R. [1 ]
Wang, Nan [1 ]
机构
[1] Columbia Univ, Dept Med, Med Ctr, Div Mol Med, 630 W 168th St, New York, NY 10032 USA
[2] Columbia Univ, Columbia Ctr Translat Immunol, Med Ctr, New York, NY USA
[3] Tianjin Med Univ, Tianjin Key Lab Metab Dis, Dept Physiol & Pathophysiol, Tianjin, Peoples R China
[4] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA
[6] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent, Munich, Germany
[7] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Area Dev & Cell Biol, Madrid, Spain
[8] Karolinska Inst, Dept Physiol & Pharmacol FyFa, Stockholm, Sweden
[9] German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany
基金
美国国家卫生研究院;
关键词
atherosclerosis; erythrocytes; inflammation; inflammasomes; macrophages; CELL DISTRIBUTION WIDTH; TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE DISORDERS; CLONAL HEMATOPOIESIS; PLAQUE NECROSIS; NEUTROPHIL RECRUITMENT; ACTIVATED PLATELETS; APOLIPOPROTEIN-E; MUTATION;
D O I
10.1161/CIRCRESAHA.118.313283
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: The mechanisms driving atherothrombotic risk in individuals with JAK2(V617F) (Jak2(VF)) positive clonal hematopoiesis or myeloproliferative neoplasms are poorly understood. Objective: The goal of this study was to assess atherosclerosis and underlying mechanisms in hypercholesterolemic mice with hematopoietic Jak2(VF) expression. Methods and Results: Irradiated low-density lipoprotein receptor knockout (Ldlr(-/-)) mice were transplanted with bone marrow from wild-type or Jak2(VF) mice and fed a high-fat high-cholesterol Western diet. Hematopoietic functions and atherosclerosis were characterized. After 7 weeks of Western diet, Jak2(VF) mice showed increased atherosclerosis. Early atherosclerotic lesions showed increased neutrophil adhesion and content, correlating with lesion size. After 12 weeks of Western diet, Jak2(VF) lesions showed increased complexity, with larger necrotic cores, defective efferocytosis, prominent iron deposition, and costaining of erythrocytes and macrophages, suggesting erythrophagocytosis. Jak2(VF) erythrocytes were more susceptible to phagocytosis by wild-type macrophages and showed decreased surface expression of CD47, a "don't-eat-me" signal. Human JAK2VF erythrocytes were also more susceptible to erythrophagocytosis. Jak2(VF) macrophages displayed increased expression and production of proinflammatory cytokines and chemokines, prominent inflammasome activation, increased p38 MAPK (mitogen-activated protein kinase) signaling, and reduced levels of MerTK (c-Mer tyrosine kinase), a key molecule mediating efferocytosis. Increased erythrophagocytosis also suppressed efferocytosis. Conclusions: Hematopoietic Jak2(VF) expression promotes early lesion formation and increased complexity in advanced atherosclerosis. In addition to increasing hematopoiesis and neutrophil infiltration in early lesions, Jak2(VF) caused cellular defects in erythrocytes and macrophages, leading to increased erythrophagocytosis but defective efferocytosis. These changes promote accumulation of iron in plaques and increased necrotic core formation which, together with exacerbated proinflammatory responses, likely contribute to plaque instability.
引用
收藏
页码:E35 / E47
页数:13
相关论文
共 50 条
  • [1] Accelerated Atherosclerosis and Thrombosis in Jak2v617f Mice
    Wang, Wei
    Liu, Wenli
    Wang, Ying
    Tang, Yang
    Woods, Brittany
    Welch, Carrie
    Cai, Bishuang
    Ai, Ding
    Yang, Yong-Guang
    Silvestre, Carlos
    Soehnlein, Oliver
    Tabas, Ira
    Levine, Ross L.
    Tall, Alan R.
    Wang, Nan
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [2] Erythroid lineage Jak2V617F expression promotes atherosclerosis through erythrophagocytosis and macrophage ferroptosis
    Liu, Wenli
    Ostberg, Nataliya
    Yalcinkaya, Mustafa
    Dou, Huijuan
    Endo-Umeda, Kaori
    Tang, Yang
    Hou, Xintong
    Xiao, Tong
    Fidler, Trevor P.
    Abramowicz, Sandra
    Yang, Yong-Guang
    Soehnlein, Oliver
    Tall, Alan R.
    Wang, Nan
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (13):
  • [3] JAK2V617F Promotes Atherosclerosis
    Wang, Wei
    Wang, Ying
    Woods, Brittany
    Abramowicz, Sandra
    Welch, Carrie
    Levine, Ross L.
    Tall, Alan
    Wang, Nan
    BLOOD, 2016, 128 (22)
  • [4] Platelet Phenotype and Thrombosis In JAK2V617F Mice
    Lamrani, Lamia
    Lacout, Catherine
    Ollivier, Veronique
    Hoe, Benoit H. O. Tin
    Vainchenker, William
    Villeval, Jean-Luc
    Jandrot-Perrus, Martine
    BLOOD, 2011, 118 (21) : 283 - 283
  • [5] The JAK2V617F mutation and thrombosis
    Austin, S. K.
    Lambert, J. R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (03) : 307 - 320
  • [6] JAK2V617F Red Blood Cells Promote Atherosclerosis and Thrombosis
    Liu, Wenli
    CIRCULATION, 2021, 144
  • [7] Jak2V617F Reversible Activation Shows an Essential Requirement for Jak2V617F in Myeloproliferative Neoplasms (MPNs)
    Dunbar, Andrew
    Bowman, Robert L.
    Park, Young
    Izzo, Franco
    Myers, Robert M.
    Karzai, Abdul
    Kim, Won Jun
    Maestre, Ines Fernandez
    Waarts, Michael R.
    Nazir, Abbas
    Xiao, Wenbin
    Brodsky, Max
    Farina, Mirko
    Cai, Louise
    Cai, Sheng F.
    Wang, Benjamin
    An, Wenbin
    Yang, Julie
    Mowla, Shoron
    Eisman, Shira E.
    Mishra, Tanmay
    Houston, Remie
    Guzzardi, Emily
    Benitez, Anthony R. Martinez
    Viny, Aaron D.
    Koche, Richard
    Landau, Dan A.
    Levine, Ross L.
    BLOOD, 2022, 140
  • [8] Interleukin-1β, JAK2V617F mutation and inflammation in MPNs
    Hermouet, Sylvie
    Hasselbalch, Hans C.
    BLOOD ADVANCES, 2024, 8 (16) : 4344 - 4347
  • [9] Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice
    Xing, Shu
    Zhao, Zhizhuang Joe
    BLOOD, 2007, 110 (11) : 745A - 745A
  • [10] Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice
    Xing, Shu
    Ho, Wanting Tina
    Zhao, Wanming
    Ma, Junfeng
    Wang, Shaofeng
    Xu, Xuesong
    Li, Qingshan
    Fu, Xueqi
    Xu, Mingjiang
    Zhao, Zhizhuang Joe
    BLOOD, 2008, 111 (10) : 5109 - 5117